Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception

Neuropharmacology

Volumn 40, Issue 3, 2001, Pages 319-326

  Palazzo, E ^a   Marabese, I ^a   De Novellis, V ^a   Oliva, P ^a   Rossi, F ^a   Berrino, L ^a   Rossi, F Sca ^a   Maione, S ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Analgesia; Cannabinoids; Metabotropic glutamate receptors; Periaqueductal grey matter; Rat

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 2 CHLORO 5 HYDROXYPHENYLGLYCINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 7 (HYDROXYIMINO)CYCLOPROPA[B]CHROMEN 1ALPHA CARBOXYLATE; ALPHA METHYLSERINE O PHOSPHATE; CANNABINOID; CANNABINOID RECEPTOR ANTAGONIST; GLUTAMATE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RIMONABANT; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MALE; MICROINJECTIONS; MORPHOLINES; NAPHTHALENES; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, DRUG; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0035134263     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00160-X     Document Type: Article

References (51)

1. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry
2. The effect of Metenkephalin on the periaqueductal gray neurons of the rat: An in vitro study
3. 9-Nor-9-beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: Comparison with morphine
4. Analgesic activity of 9-tetrahydrocannabinol in the rat and mouse
5. Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat
6. Metabotropic glutamate receptor heterogeneity in rat brain
7. Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distint from Δ9-tetrahydrocannabinol
8. Pharmacological profile of a series of bicyclic cannabinoid analog-classification as cannabimimetic agents
9. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities
10. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
11. Determination and characterization of a cannabinoid receptor in rat brain
12. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
13. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
14. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
15. Research in complementary medicine
16. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
17. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2
18. A pharmacological analysis of levantrandol antinociception in mice
19. Paradoxical effects after microinjection of morphine in the periaqueductal gray matter in the rat
20. Spinal monoamine and opiate systems partly mediate the antinociceptive effect produced by glutamate at brainstem sites
21. Comparison of the antinociceptive effect of morphine and glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats
22. Antagonism of presinaptically mediated depressant responces and cyclic AMP-coupled metabotropic glutamate receptors
23. Metabotropic and ionotropic glutamate receptors mediate opposite effects on periaqueductal gray matter
24. Spinal and supraspinal components of cannabinoid-induced antinociception
25. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement
26. Pharmacology and stereoselectivity of structurally novel cannabinoid in mice
27. Characterisation of mGluRs which modulate nociception in the PAG of mouse
28. PAG matter metabotropic glutamate receptors modulate formalin-induced nociception
29. Cellular localization of a metabotropic glutamate receptor in rat brain
30. Antinociceptive actions of cannabinoids following intraventricular administration in rats
31. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects
32. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
33. An analgesic circuit activated by cannabinoids
34. Evidences for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission
35. Tonic analgesic effect of delta 9-tetrahydrocannabinol as measured with the formalin test
36. The analgesic properties of delta-9-tetrahydrocannabinol and codeine
37. The metabotropic glutamate receptors: Structure and functions
38. Structure-activity relationships in cannabinoids
39. Surgery in the electrical analgesia induced by focal brain stimulation
40. Modulatory of sensory neurone excitatory and inhibitory responses in the ventrobasal thalamus by activation of metabotropic excitatory amino acid receptors
41. Antagonism of mGlu5 2-chloro-5-hydroxyphenylglycine by the novel selective mGlu5 antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) in the thalamus
42. Target-cell specific concentration of a metabotropic glutamate receptor in the presynaptic active zone
43. Characterization of delta9-tetra-hydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats
44. Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC)
45. Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist
46. Glutamate-induced analgesia: Blockade and potentiation by naloxone
47. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro
48. The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors
49. Effects of cannabinoids on the abdominal constriction response in mice: Within cannabinoid interactions
50. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray